Marc Vervloet

Associate professor

University of Amsterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marc Vervloet is an Associate Professor at Vrije Universiteit Amsterdam, Netherlands. His research focuses on chronic kidney disease, with particular emphasis on mineral and bone disorders, the role of vitamin D, and autonomic nervous system dysregulation in relation to bone health. He has published recent articles addressing various aspects of CKD management, including nutritional interventions and arterial stiffness.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Rafael Kramann

RWTH Aachen University

GERMANY

View details

Goos Laverman

University of Twente

NETHERLANDS

View details

Daniel van Raalte

NETHERLANDS

View details

Joline W. J. Beulens

NETHERLANDS

View details

Sandro Mazzaferro

Full Professor of Nephrology

Sapienza University of Rome

ITALY

View details

Hirotaka Komaba

Associate Professor

Tokai University School of Medicine

JAPAN

View details

Mandy Wan

King’s College London

UNITED KINGDOM

View details

Hanne Mari Skou Jørgensen

Associate Professor

Aarhus University

DENMARK

View details

Etienne Cavalier

Professor

University of Liege

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marc Vervloet

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation - a European consensus statement.

Autonomic Nervous System Dysregulation and Bone Health in Patients with CKD

Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Response to Letter to the Editor From Sumi et al: “Lower Bone Turnover and Skeletal PTH Responsiveness in Japanese Compared to European Patients Receiving Hemodialysis”

Vitamin D supplementation in people with chronic kidney disease

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?

Magnesium Administration in Chronic Kidney Disease

Lower Bone Turnover and Skeletal PTH Responsiveness in Japanese Compared to European Patients on Hemodialysis

Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.

Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease

Shedding Light on the Complex Regulation of FGF23

Combining phosphate binder therapy with vitamin K2 inhibits vascular calcification in an experimental animal model of kidney failure

Does vitamin K crack calcification in the Chronic Renal Insufficiency Cohort (CRIC)?

Collaborators (9)

Rafael Kramann

Goos Laverman

Daniel van Raalte

Joline W. J. Beulens

Sandro Mazzaferro

Hirotaka Komaba

Mandy Wan

Hanne Mari Skou Jørgensen

Etienne Cavalier

Make your next move.